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Formulas based on protein hydrolysates or free amino
acids are used to manage food allergies in infants and
young children. Three formula categories are available:
Products containing partially hydrolyzed proteins which
show some decrease in clinical reactivity but are not
recommended for food-allergic infants, formulas based
on extensively hydrolyzed proteins that are useful in
clinical management of food allergies in >90% of
patients, and free amino acid-based formulas used for
the most strongly allergic patients.
Formula hypoallergenic reactivity is only established
by clinical trials, but these studies should be preceded
by evaluation in appropriate animal models. For partially
hydrolyzed formulas the goal of the model is to demon-
strate some reduction in immunologic reactivity that
justifies their “Hypoallergenic, not for use in food-aller-
gic infants” labeling. For formulas based on extensively
hydrolyzed proteins or amino acids, results of the ani-
mal models must predict the accepted standard for
hypoallergenic clinical performance (Double-blinded,
placebo-controlled food challenges indicating 90% of
allergic patients tolerate the formula, 95% CI).
Guinea pig oral sensitization is used to show
decreased immunological reactivity of partially hydro-
lyzed formulas. Model sensitivity can be controlled by
varying feeding duration, with positive controls (intact
cow milk formula) reacting after a 15 day feeding. How-
ever, some partially hydrolyzed formulae that give nega-
tive results with 15 day feedings are sensitizing if fed for
35 days. Extensively hydrolyzed and amino acid formu-
las fed 35 days are not sensitizing. Symptom standards
for evaluating reactions will be presented along with for-
mula type and feeding duration comparisons.
The laboratory animal hyperimmunization model is
sensitive at the lower end of the immunological reactiv-
ity scale and can be used to differentiate extensively
hydrolyzed and amino acid formulas which meet hypoal-
lergenic clinical performance standards from partially
hydrolyzed formulas not recommended for allergic
patients. Analytical considerations and formula type
comparisons will be presented.
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